PlainRecalls
FDA Drug Moderate Class II Ongoing

Labetalol Hydrochloride Injection, USP, 20 mg/4 mL (5 mg/mL), 4 mL Single-dose Carpuject, Sterile Cartridge Unit with Luer Lock, For Intravenous Injection Only, Rx Only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA. NDC: 0409-2339-24

Reported: July 3, 2024 Initiated: May 20, 2024 #D-0565-2024

Product Description

Labetalol Hydrochloride Injection, USP, 20 mg/4 mL (5 mg/mL), 4 mL Single-dose Carpuject, Sterile Cartridge Unit with Luer Lock, For Intravenous Injection Only, Rx Only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA. NDC: 0409-2339-24

Reason for Recall

Lack of Assurance of Sterility-The potential for incomplete crimp seals.

Details

Recalling Firm
Pfizer Inc.
Units Affected
220,400 cartridges
Distribution
US Nationwide and Puerto Rico.
Location
New York, NY

Frequently Asked Questions

What product was recalled?
Labetalol Hydrochloride Injection, USP, 20 mg/4 mL (5 mg/mL), 4 mL Single-dose Carpuject, Sterile Cartridge Unit with Luer Lock, For Intravenous Injection Only, Rx Only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA. NDC: 0409-2339-24. Recalled by Pfizer Inc.. Units affected: 220,400 cartridges.
Why was this product recalled?
Lack of Assurance of Sterility-The potential for incomplete crimp seals.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 3, 2024. Severity: Moderate. Recall number: D-0565-2024.